日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Salicylates enhance CRM1 inhibitor antitumor activity by induction of S-phase arrest and impairment of DNA-damage repair.

水杨酸盐通过诱导 S 期阻滞和损害 DNA 损伤修复来增强 CRM1 抑制剂的抗肿瘤活性

Abeykoon Jithma P, Wu Xiaosheng, Nowakowski Kevin E, Dasari Surendra, Paludo Jonas, Weroha S John, Hu Chunling, Hou Xiaonan, Sarkaria Jann N, Mladek Ann C, Phillips Jessica L, Feldman Andrew L, Ravindran Aishwarya, King Rebecca L, Boysen Justin, Stenson Mary J, Carr Ryan M, Manske Michelle K, Molina Julian R, Kapoor Prashant, Parikh Sameer A, Kumar Shaji, Robinson Steven I, Yu Jia, Boughey Judy C, Wang Liewei, Goetz Matthew P, Couch Fergus J, Patnaik Mrinal M, Witzig Thomas E

MCIR1: A patient-derived mantle cell lymphoma line for discovering new treatments for ibrutinib resistance

MCIR1:一种源自患者的套细胞淋巴瘤细胞系,用于发现伊布替尼耐药性的新疗法

Wu, Xiaosheng; Nowakowski, Kevin E; Abeykoon, Jithma P; Manske, Michelle; Stenson, Mary J; Timm, Michael M; Hanson, Curtis A; Van Dyke, Daniel L; Dasari, Surendra; Witzig, Thomas E

The effect of CRM1 inhibition on human non-Hodgkin lymphoma cells

CRM1抑制对人非霍奇金淋巴瘤细胞的影响

Abeykoon, Jithma P; Paludo, Jonas; Nowakowski, Kevin E; Stenson, Mary J; King, Rebecca L; Wellik, Linda E; Wu, Xiaosheng; Witzig, Thomas E